Quarterly report · Q3

Period2023-04-01 → 2023-12-31
Filed2024-02-08
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 35
MetricValuePeriodScopeSource row
Revenue¥16.9bn2023-04-01 → 2023-12-31Cons.Net sales
Revenue¥22.2bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥16.5bn2022-04-01 → 2022-12-31Cons.Net sales
Operating income¥278m2023-04-01 → 2023-12-31Cons.Operating income
Operating income¥39m2022-04-01 → 2022-12-31Cons.Operating income
Ordinary income¥275m2023-04-01 → 2023-12-31Cons.Ordinary income
Ordinary income¥169m2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥12m2022-04-01 → 2022-12-31Cons.Ordinary income
Profit before tax¥204m2023-04-01 → 2023-12-31Cons.Income before income taxes
Profit before tax−¥59m2022-04-01 → 2022-12-31Cons.Income before income taxes
Net income (owners)¥118m2023-04-01 → 2023-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥210m2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)−¥59m2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income¥118m2023-04-01 → 2023-12-31Cons.Profit loss
Net income−¥59m2022-04-01 → 2022-12-31Cons.Profit loss
Total assets¥14.2bnat 2023-12-31Cons.Assets
Total assets¥14.1bnat 2023-03-31Cons.Assets
Total assets¥14.0bnat 2022-12-31Cons.Total assets (5-year summary)
Total liabilities¥10.8bnat 2023-12-31Cons.Liabilities
Total liabilities¥10.8bnat 2023-03-31Cons.Liabilities
Net assets / equity¥3.4bnat 2023-12-31Cons.Net assets
Net assets / equity¥3.3bnat 2023-03-31Cons.Net assets
Net assets / equity¥3.1bnat 2022-12-31Cons.Net assets (5-year summary)
Cash and deposits¥1.8bnat 2023-12-31Cons.Cash and deposits
Cash and deposits¥1.3bnat 2023-03-31Cons.Cash and deposits
EPS (basic)¥47.152023-04-01 → 2023-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥59.822023-10-01 → 2023-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥84.222022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-23.692022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-5.862022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥46.872023-04-01 → 2023-12-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥83.842022-04-01 → 2023-03-31Cons.Diluted earnings per share (5-year summary)
Equity ratio23.9%at 2023-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio23.6%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio21.9%at 2022-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 46
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-04-01 → 2023-12-31¥715m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2023-04-01 → 2023-12-31¥682m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2023-04-01 → 2023-12-31¥33m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-04-01 → 2023-12-31¥21m
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-12-31−¥33m
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-12-31−¥33m
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-12-31−¥569m
jpcrp040300-q3r_E36714-000Medicinereportable segmentrevenue2023-04-01 → 2023-12-31¥6.9bn
jpcrp040300-q3r_E36714-000Medicinereportable segmentrevenue external2023-04-01 → 2023-12-31¥6.9bn
jpcrp040300-q3r_E36714-000Medicinereportable segmentsegment profit2023-04-01 → 2023-12-31¥391m
jpcrp040300-q3r_E36714-000Nursing Care Businessreportable segmentrevenue2023-04-01 → 2023-12-31¥2.5bn
jpcrp040300-q3r_E36714-000Nursing Care Businessreportable segmentrevenue external2023-04-01 → 2023-12-31¥2.5bn
jpcrp040300-q3r_E36714-000Nursing Care Businessreportable segmentsegment profit2023-04-01 → 2023-12-31−¥82m
jpcrp040300-q3r_E36714-000Nurturing Businessreportable segmentrevenue2023-04-01 → 2023-12-31¥6.8bn
jpcrp040300-q3r_E36714-000Nurturing Businessreportable segmentrevenue external2023-04-01 → 2023-12-31¥6.8bn
jpcrp040300-q3r_E36714-000Nurturing Businessreportable segmentsegment profit2023-04-01 → 2023-12-31¥516m
—segment totalrevenue2023-04-01 → 2023-12-31¥16.2bn
—segment totalrevenue external2023-04-01 → 2023-12-31¥16.2bn
—segment totalsegment profit2023-04-01 → 2023-12-31¥826m
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-12-31¥16.9bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-12-31¥16.9bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-04-01 → 2023-12-31¥33m
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-12-31¥847m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2022-12-31¥708m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2022-12-31¥688m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-04-01 → 2022-12-31¥21m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-12-31¥29m
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-12-31−¥21m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-12-31−¥21m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-12-31−¥581m
jpcrp040300-q3r_E36714-000Medicinereportable segmentrevenue2022-04-01 → 2022-12-31¥6.7bn
jpcrp040300-q3r_E36714-000Medicinereportable segmentrevenue external2022-04-01 → 2022-12-31¥6.7bn
jpcrp040300-q3r_E36714-000Medicinereportable segmentsegment profit2022-04-01 → 2022-12-31¥380m
jpcrp040300-q3r_E36714-000Nursing Care Businessreportable segmentrevenue2022-04-01 → 2022-12-31¥2.6bn
jpcrp040300-q3r_E36714-000Nursing Care Businessreportable segmentrevenue external2022-04-01 → 2022-12-31¥2.6bn
jpcrp040300-q3r_E36714-000Nursing Care Businessreportable segmentsegment profit2022-04-01 → 2022-12-31−¥108m
jpcrp040300-q3r_E36714-000Nurturing Businessreportable segmentrevenue2022-04-01 → 2022-12-31¥6.5bn
jpcrp040300-q3r_E36714-000Nurturing Businessreportable segmentrevenue external2022-04-01 → 2022-12-31¥6.5bn
jpcrp040300-q3r_E36714-000Nurturing Businessreportable segmentsegment profit2022-04-01 → 2022-12-31¥319m
—segment totalrevenue2022-04-01 → 2022-12-31¥15.8bn
—segment totalrevenue external2022-04-01 → 2022-12-31¥15.8bn
—segment totalsegment profit2022-04-01 → 2022-12-31¥591m
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-12-31¥16.6bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-12-31¥16.5bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-12-31¥21m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-12-31¥619m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 406
ItemContextValueUnit
Independent auditors report consolidated (text)FilingDateInstantText · Plus
Audit firm1 consolidatedFilingDateInstant
Original text (Japanese)史彩監査法人
Cpa1 audit firm1 consolidatedFilingDateInstant
Original text (Japanese)伊  藤     肇
Cpa2 audit firm1 consolidatedFilingDateInstant
Original text (Japanese)田  和  大  人
Number of submissionFilingDateInstant1
Net sales (5-year summary)Prior1YTDDuration16533214000JPY
Net sales (5-year summary)CurrentYTDDuration16886834000JPY
Net sales (5-year summary)Prior1YearDuration22249391000JPY
Ordinary income loss (5-year summary)Prior1YTDDuration11974000JPY
Ordinary income loss (5-year summary)CurrentYTDDuration275306000JPY
Ordinary income loss (5-year summary)Prior1YearDuration169277000JPY
Profit loss attributable to owners of parent (5-year summary)Prior1YTDDuration-58960000JPY
Profit loss attributable to owners of parent (5-year summary)CurrentYTDDuration117760000JPY
Profit loss attributable to owners of parent (5-year summary)Prior1YearDuration209580000JPY
Comprehensive income (5-year summary)Prior1YTDDuration-58968000JPY
Comprehensive income (5-year summary)CurrentYTDDuration117775000JPY
Comprehensive income (5-year summary)Prior1YearDuration209585000JPY
Net assets (5-year summary)Prior1QuarterInstant3069179000JPY
Net assets (5-year summary)CurrentQuarterInstant3403252000JPY
Net assets (5-year summary)Prior1YearInstant3337732000JPY
Total assets (5-year summary)Prior1QuarterInstant13990702000JPY
Total assets (5-year summary)CurrentQuarterInstant14247860000JPY
Total assets (5-year summary)Prior1YearInstant14135911000JPY
Basic earnings loss per share (5-year summary)Prior1YTDDuration-23.69
Basic earnings loss per share (5-year summary)CurrentYTDDuration47.15
Basic earnings loss per share (5-year summary)Prior1YearDuration84.22
Diluted earnings per share (5-year summary)Prior1YTDDuration-
Diluted earnings per share (5-year summary)CurrentYTDDuration46.87
Diluted earnings per share (5-year summary)Prior1YearDuration83.84
Equity to asset ratio (5-year summary)Prior1QuarterInstant0.219
Equity to asset ratio (5-year summary)CurrentQuarterInstant0.239
Equity to asset ratio (5-year summary)Prior1YearInstant0.236
Basic earnings loss per share (5-year summary)Prior1QuarterDuration-5.86
Basic earnings loss per share (5-year summary)CurrentQuarterDuration59.82
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember2512300
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember2512300
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant2512300
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant2512300
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithNoVotingRightsMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember-
Number of voting rights issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember-
Number of voting rights issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember25014
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember2501400
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember900
Number of shares issued shares voting rightsCurrentQuarterInstant2502300
Number of voting rights issued shares voting rightsCurrentQuarterInstant25014
Cash and depositsPrior1YearInstant1265326000JPY
Cash and depositsCurrentQuarterInstant1821227000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-12-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2023-04-01/2023-12-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass